Stockscreener 앱 받기
13.25
9.32%
1.13
시간 외 거래:
13.25
전일 마감가:
$12.12
열려 있는:
$12.24
하루 거래량:
120.13K
Relative Volume:
0.65
시가총액:
$191.10M
수익:
$6.39M
순이익/손실:
$-117.26M
주가수익비율:
-1.0616
EPS:
-12.4807
순현금흐름:
$-79.08M
1주 성능:
+27.77%
1개월 성능:
-8.56%
6개월 성능:
+5.41%
1년 성능:
-16.46%
1일 변동 폭
$12.24
$13.30
1주일 범위
$10.22
$13.30
52주 변동 폭
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
13.25 | 154.61M | 6.39M | -117.26M | -79.08M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-11-13 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Korro Bio Inc (KRRO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
KRRO|Korro Bio Inc|Price:10.640|Chg%:-0.890 - TradingKey
Korro Bio Inc (KRRO) Institutional Confidence - TradingKey
Korro Bio Inc (KRRO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Korro Bio, Inc. Revenue Breakdown – NASDAQ:KRRO - TradingView
Korro Bio Inc (KRRO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Korro Bio Inc (KRRO) Cash Flow - TradingKey
Korro Bio Inc (KRRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Korro Bio Inc (KRRO) Balance Sheet - TradingKey
TradingKey - TradingKey
Korro Bio Inc (KRRO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
KRRO|Korro Bio Inc|Price:10.700|Chg%:+0.060 - TradingKey
Korro Bio Inc (KRRO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Korro Bio, Inc. explores novel RNA editing approach for urea cycle disorder treatment - Traders Union
Form 4 Korro Bio Inc For: 17 July By Investing.com - Investing.com Nigeria
Korro Bio, Inc. (KRRO) awards 7,500 RSUs to Chief Operating Officer - Stock Titan
Korro Bio (KRRO) grants 6,500 RSUs to General Counsel Jeffrey Cerio - Stock Titan
Korro Bio Inc. (KRRO) Slides 7% as Shares Test Key Support LevelsRange Breakout - dars.gov.et
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Price to earnings forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Price to sales forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Korro Bio, Inc. (KRRO) upgraded to buy: What does it mean for the stock? - MSN
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
KRRO Q1 2026 Earnings: EPS Beat Driven by Cost Control and Clinical ProgressRevenue Report - dars.gov.et
Korro Bio: Why Director Sales Temper a 'Strong Buy' Consensus - Kavout | AI
Korro Bio director Formela sells $1.54m in shares - Investing.com
Korro Bio director Formela sells $1.54m in shares By Investing.com - Investing.com South Africa
Form 4 Korro Bio Inc For: 7 July By Investing.com - Investing.com Canada
Frontier tech research, news & data - MLQ.ai
Price to book forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Form 144 Korro Bio For: 6 July By Investing.com - Investing.com Canada
Atlas Venture affiliates sell blocks of KRRO stock (KRRO) - Stock Titan
Korro Bio, Inc. (KRRO) soars 17.6%: Is further upside left in the stock? - MSN
KRRO Q1 2026 Earnings: EPS Surpasses Estimates Amid Ongoing Clinical ProgressSlow Growth Warning - dars.gov.et
KRROKorro Bio Inc Options - Finviz
Form 144 Korro Bio For: 2 July By Investing.com - Investing.com India
Korro Bio Inc. (KRRO) Gains 3.9% as Biotech Stock Tests Key Resistance LevelDark Pool Volume - dars.gov.et
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 2500 Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 2000 Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 3000E Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Korro Bio, Inc. Actuals & Estimates (NASDAQ:KRRO) - TradingView
KRRO Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Korro Bio Inc For: 24 June By Investing.com - Investing.com Nigeria
Korro Bio Insider Sold Shares Worth $2,458,582, According to a Recent SEC Filing - marketscreener.com
Korro Bio director Jean Francois Formela sells $2.45m in shares - Investing.com UK
Korro Bio (KRRO) director-affiliated Atlas funds sell 171K shares under 10b5-1 plan - Stock Titan
Form 144 Korro Bio For: 24 June By Investing.com - Investing.com India
Atlas Venture (KRRO) sells 101,579 shares on 06/23/2026, multiple Form 144 entries - Stock Titan
Atlas Venture sells KRRO common stock in late May–June 2026 (KRRO) - Stock Titan
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.86%
자본화:
|
볼륨(24시간):